Crossmark

Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?

Published Online: 2018-04-18

Published Print: 2018-12

Authors

Tang, Fei https://orcid.org/0000-0003-1475-5028
Du, Xuexiang

Liu, Mingyue

Zheng, Pan

Liu, Yang
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (AI64350)

National Cancer Institute (CA171972)

National Institute on Aging (AG036690)
License Information

Text and Data Mining valid from 2018-04-18

Version of Record valid from 2018-04-18
More Information

Article History

Received: 24 March 2018

Accepted: 13 April 2018

First Online: 18 April 2018

Document is current